Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot study.

Hahn B, Shrieves ME, Yuille MB, Buchanan RW, Wells AK.

Psychiatry Res. 2019 Jul 29;280:112498. doi: 10.1016/j.psychres.2019.112498. [Epub ahead of print]

PMID:
31437659
2.

Review of non-clinical risk models to aid prevention of breast cancer.

Al-Ajmi K, Lophatananon A, Yuille M, Ollier W, Muir KR.

Cancer Causes Control. 2018 Oct;29(10):967-986. doi: 10.1007/s10552-018-1072-6. Epub 2018 Sep 3. Review.

3.

Nicotine effects on associative learning in human non-smokers.

Hahn B, Wells AK, Lenartowicz A, Yuille MB.

Neuropsychopharmacology. 2018 Oct;43(11):2190-2196. doi: 10.1038/s41386-018-0183-9. Epub 2018 Aug 17.

PMID:
30131565
4.

Risk biomarkers enable precision in public health.

Ollier W, Muir KR, Lophatananon A, Verma A, Yuille M.

Per Med. 2018 Jul 1;15(4):329-342. doi: 10.2217/pme-2017-0068. Epub 2018 Jun 29. Review.

PMID:
29957132
5.

Financial Sustainability of Biobanks: From Theory to Practice.

Yuille MM, Feller PI, Georghiou L, Laredo P, Welch EW.

Biopreserv Biobank. 2017 Apr;15(2):85-92. doi: 10.1089/bio.2017.29019.mjy. Epub 2017 Mar 29. No abstract available.

PMID:
28353358
6.

Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore HM, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G.

Biopreserv Biobank. 2017 Jun;15(3):270-276. doi: 10.1089/bio.2016.0053. Epub 2016 Dec 19. No abstract available.

7.

A test of the cognitive-enhancing potential of low-dose mecamylamine in healthy non-smokers.

Yuille MB, Olmstead CK, Wells AK, Hahn B.

Psychopharmacology (Berl). 2017 Jan;234(1):109-116. doi: 10.1007/s00213-016-4443-2. Epub 2016 Sep 27.

8.

Biobank Finances: A Socio-Economic Analysis and Review.

Gee S, Oliver R, Corfield J, Georghiou L, Yuille M.

Biopreserv Biobank. 2015 Dec;13(6):435-51. doi: 10.1089/bio.2015.0030. Review.

PMID:
26697914
9.

Brave New World.

Yuille M.

Biopreserv Biobank. 2015 Dec;13(6):433-4. doi: 10.1089/bio.2015.29040.my. No abstract available.

PMID:
26697913
10.

Research investment disparities in England.

Yuille M, Harrison A, Williams G, Verma A.

Lancet. 2015 May 9;385(9980):1830. doi: 10.1016/S0140-6736(15)60919-9. No abstract available.

PMID:
25987148
11.

Public biobanks: calculation and recovery of costs.

Clément B, Yuille M, Zaltoukal K, Wichmann HE, Anton G, Parodi B, Kozera L, Bréchot C, Hofman P, Dagher G; EU-US Expert Group on cost recovery in biobanks.

Sci Transl Med. 2014 Nov 5;6(261):261fs45. doi: 10.1126/scitranslmed.3010444.

PMID:
25378642
12.

The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

West C, Azria D, Chang-Claude J, Davidson S, Lambin P, Rosenstein B, De Ruysscher D, Talbot C, Thierens H, Valdagni R, Vega A, Yuille M.

Clin Oncol (R Coll Radiol). 2014 Dec;26(12):739-42. doi: 10.1016/j.clon.2014.09.008. Epub 2014 Sep 27. No abstract available.

PMID:
25267305
13.

Course fees and academic ranking: insights from the IMI EMTRAIN on-course® database.

Payton A, Dallakian P, Fitton A, Payton A, Hardman M, Yuille M.

Drug Discov Today. 2014 Jul;19(7):830-3. doi: 10.1016/j.drudis.2013.12.001. Epub 2013 Dec 8. Review.

PMID:
24325828
14.

Toward a roadmap in global biobanking for health.

Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M, Brookes AJ, Budin-Ljøsne I, Chisholm R, Cox D, Deschênes M, Fortier I, Hainaut P, Hewitt R, Kaye J, Litton JE, Metspalu A, Ollier B, Palmer LJ, Palotie A, Pasterk M, Perola M, Riegman PH, van Ommen GJ, Yuille M, Zatloukal K.

Eur J Hum Genet. 2012 Nov;20(11):1105-11. doi: 10.1038/ejhg.2012.96. Epub 2012 Jun 20.

15.

Selection and Implementation of the ISO9001 Standard to Support Biobanking Research Infrastructure Development.

Davis E, Hampson K, Bray C, Dixon K, Ollier W, Yuille M.

Biopreserv Biobank. 2012 Apr;10(2):162-7. doi: 10.1089/bio.2011.0044. Epub 2012 Feb 7.

PMID:
24844905
16.

Sources of variability between biobanks in the estimation of DNA concentration.

Jury F, Morris J, Davis E, Ollier W, Yuille M.

Biopreserv Biobank. 2012 Feb;10(1):55-61. doi: 10.1089/bio.2011.0043. Epub 2012 Jan 17.

PMID:
24849754
17.

Comprehensive catalog of European biobanks.

Wichmann HE, Kuhn KA, Waldenberger M, Schmelcher D, Schuffenhauer S, Meitinger T, Wurst SH, Lamla G, Fortier I, Burton PR, Peltonen L, Perola M, Metspalu A, Riegman P, Landegren U, Taussig MJ, Litton JE, Fransson MN, Eder J, Cambon-Thomsen A, Bovenberg J, Dagher G, van Ommen GJ, Griffith M, Yuille M, Zatloukal K.

Nat Biotechnol. 2011 Sep 8;29(9):795-7. doi: 10.1038/nbt.1958. No abstract available.

PMID:
21904320
18.

Infrastructure vital to genome success.

Yuille M.

Nature. 2011 Mar 10;471(7337):166. doi: 10.1038/471166c. No abstract available.

PMID:
21390116
19.

Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?

Mamas MA, Deaton C, Rutter MK, Yuille M, Williams SG, Ray SG, New J, Gibson JM, Neyses L.

J Card Fail. 2010 Sep;16(9):761-8. doi: 10.1016/j.cardfail.2010.05.027. Epub 2010 Jul 21. Review.

PMID:
20797600
20.

Laboratory management of samples in biobanks: European consensus expert group report.

Yuille M, Illig T, Hveem K, Schmitz G, Hansen J, Neumaier M, Tybring G, Wichmann E, Ollier B.

Biopreserv Biobank. 2010 Mar;8(1):65-9. doi: 10.1089/bio.2010.8102. No abstract available.

PMID:
24836342
21.

Molecular medicine ireland guidelines for standardized biobanking.

Guerin JS, Murray DW, McGrath MM, Yuille MA, McPartlin JM, Doran PP.

Biopreserv Biobank. 2010 Mar;8(1):3-63. doi: 10.1089/bio.2010.8101. No abstract available.

PMID:
24836341
22.

Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order.

Jønsson V, Tjønnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M.

In Vivo. 2010 Jan-Feb;24(1):85-95.

PMID:
20133982
23.

Observational study on variability between biobanks in the estimation of DNA concentration.

Brown J, Donev AN, Aslanidis C, Bracegirdle P, Dixon KP, Foedinger M, Gwilliam R, Hardy M, Illig T, Ke X, Krinka D, Lagerberg C, Laiho P, Lewis DH, McArdle W, Patton S, Ring SM, Schmitz G, Stevens H, Tybring G, Wichmann HE, Ollier WE, Yuille MA.

BMC Res Notes. 2009 Oct 13;2:208. doi: 10.1186/1756-0500-2-208.

24.

The UK DNA banking network: a "fair access" biobank.

Yuille M, Dixon K, Platt A, Pullum S, Lewis D, Hall A, Ollier W.

Cell Tissue Bank. 2010 Aug;11(3):241-51. doi: 10.1007/s10561-009-9150-3. Epub 2009 Aug 12.

25.

Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease.

Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D.

Leuk Lymphoma. 2007 Dec;48(12):2387-96.

PMID:
18067015
26.

Biobanking for Europe.

Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G, Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, Wichmann HE, Zatloukal K.

Brief Bioinform. 2008 Jan;9(1):14-24. Epub 2007 Oct 23. Review.

PMID:
17959611
27.

Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults.

de Tute R, Yuille M, Catovsky D, Houlston RS, Hillmen P, Rawstron AC.

Leukemia. 2006 Apr;20(4):728-9. No abstract available.

PMID:
16437141
28.

A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.

Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS.

Am J Hum Genet. 2005 Sep;77(3):420-9. Epub 2005 Aug 2.

29.

CLL family 'Pedigree 14' revisited: 1947-2004.

Jønsson V, Houlston RS, Catovsky D, Yuille MR, Hilden J, Olsen JH, Fajber M, Brandt B, Sellick G, Allinson R, Wiik A.

Leukemia. 2005 Jun;19(6):1025-8.

PMID:
15800670
30.

The responsibility to share: sharing the responsibility.

Yuille M, Korn B, Moore T, Farmer AA, Carrino J, Prange C, Hayashizaki Y.

Genome Res. 2004 Oct;14(10B):2015-9. Review. No abstract available.

31.

Causation of chronic lymphocytic leukemia--insights from familial disease.

Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D.

Leuk Res. 2003 Oct;27(10):871-6. Review.

PMID:
12860003
32.

Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia.

Condie A, Powles RL, Hudson CD, Shepherd V, Bevan S, Yuille MR, Houlston RS.

Leuk Lymphoma. 2002 Sep;43(9):1849-53.

PMID:
12685843
33.

Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia.

Benzow KA, Koob MD, Condie A, Catovsky D, Matutes E, Yuille MR, Houlston RS.

Leuk Lymphoma. 2002 Oct;43(10):1987-90.

PMID:
12481897
34.

Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome.

Sodha N, Houlston RS, Bullock S, Yuille MA, Chu C, Turner G, Eeles RA.

Hum Mutat. 2002 Dec;20(6):460-2. No abstract available.

PMID:
12442270
35.

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ, Jack AS, Matutes E, Catovsky D, Hillmen P, Houlston RS.

Blood. 2002 Oct 1;100(7):2289-90.

36.

Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis.

Summersgill B, Thornton P, Atkinson S, Matutes E, Shipley J, Catovsky D, Houlston RS, Yuille MR.

Leukemia. 2002 Jul;16(7):1229-32.

37.

ATM mutations are rare in familial chronic lymphocytic leukemia.

Yuille MR, Condie A, Hudson CD, Bradshaw PS, Stone EM, Matutes E, Catovsky D, Houlston RS.

Blood. 2002 Jul 15;100(2):603-9.

38.

Genetic susceptibility to chronic lymphocytic leukemia.

Houlston RS, Catovsky D, Yuille MR.

Leukemia. 2002 Jun;16(6):1008-14. Review.

39.

Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia.

Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, Matutes E, Catovsky D, Houlston R.

Blood. 2002 Jun 1;99(11):4216-8.

40.

Analysis of CHK2 in vulval neoplasia.

Reddy A, Yuille M, Sullivan A, Repellin C, Bell A, Tidy JA, Evans DJ, Farrell PJ, Gusterson B, Gasco M, Crook T.

Br J Cancer. 2002 Mar 4;86(5):756-60.

41.

Concomitant inactivation of p53 and Chk2 in breast cancer.

Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T.

Oncogene. 2002 Feb 21;21(9):1316-24.

42.

Breakpoints in the ataxia telangiectasia gene arise at the RGYW somatic hypermutation motif.

Bradshaw PS, Condie A, Matutes E, Catovsky D, Yuille MR.

Oncogene. 2002 Jan 17;21(3):483-7.

43.

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J, Eeles RA.

Hum Mutat. 2002 Feb;19(2):173-7.

PMID:
11793476
44.

Investigation on the role of the ATM gene in chronic myeloid leukaemia.

Melo JV, Kumberova A, van Dijk AG, Goldman JM, Yuille MR.

Leukemia. 2001 Sep;15(9):1448-50.

PMID:
11516106
45.

Disruption of the ATM gene in breast cancer.

Lu Y, Condie A, Bennett JD, Fry MJ, Yuille MR, Shipley J.

Cancer Genet Cytogenet. 2001 Apr 15;126(2):97-101.

PMID:
11376801
46.

Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin.

Stankovic T, Taylor AM, Yuille MR, Vorechovsky I.

Blood. 2001 Mar 1;97(5):1517-8. No abstract available.

47.

TCL1 is activated by chromosomal rearrangement or by hypomethylation.

Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, Catovsky D.

Genes Chromosomes Cancer. 2001 Apr;30(4):336-41.

PMID:
11241786
48.

Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia.

Bevan S, Catovsky D, Matutes E, Antunovic P, Auger MJ, Ben-Bassat I, Bell A, Berrebi A, Gaminara EJ, Júnior ME, Mauro FR, Quabeck K, Rassam SM, Reid C, Ribeiro I, Stark P, van Dongen JJ, Wimperis J, Wright S, Marossy A, Yuille MR, Houlston RS.

Blood. 2000 Dec 1;96(12):3982-4.

49.

Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12.

Sorour A, Brito-Babapulle V, Smedley D, Yuille M, Catovsky D.

Cancer Genet Cytogenet. 2000 Sep;121(2):128-32.

PMID:
11063795
50.

T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation.

De Schouwer PJ, Dyer MJ, Brito-Babapulle VB, Matutes E, Catovsky D, Yuille MR.

Br J Haematol. 2000 Sep;110(4):831-8.

PMID:
11054065

Supplemental Content

Loading ...
Support Center